{"organizations": [], "uuid": "570169727939ec63f3d8b5f83c72d2ada18fb030", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-shire-plc-says-us-fda-has-accepted/brief-shire-plc-says-u-s-fda-has-accepted-biologics-license-application-for-calaspargase-pegol-idUSASB0C7XF", "country": "US", "domain_rank": 408, "title": "BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-02-28T15:21:00.000+02:00", "replies_count": 0, "uuid": "570169727939ec63f3d8b5f83c72d2ada18fb030"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shire-plc-says-us-fda-has-accepted/brief-shire-plc-says-u-s-fda-has-accepted-biologics-license-application-for-calaspargase-pegol-idUSASB0C7XF", "ord_in_thread": 0, "title": "BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "shire plc", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-shire plc says ‍u.s. fda", "sentiment": "neutral"}, {"name": "bla", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 28, 2018 / 7:21 AM / Updated 39 minutes ago BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​ Reuters Staff 1 Min Read Feb 28 (Reuters) - Shire Plc: * U.S. FDA ACCEPTS SHIRE‘S BIOLOGICS LICENSE APPLICATION FOR CALASPARGASE PEGOL (CAL-PEG) FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) * ‍U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED BIOLOGICS LICENSE APPLICATION (BLA) FOR CALASPARGASE PEGOL​ Source text for Eikon: Further company coverage:", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T15:21:00.000+02:00", "crawled": "2018-02-28T10:02:03.011+02:00", "highlightTitle": ""}